New anti-tuberculosis drugs for special populations: A difficult-to-address issue

European Respiratory Journal

Volumn 48, Issue 3, 2016, Pages 957-958

  Sotgiu, Giovanni ^a   Pontali, Emanuele ^b   Centis, Rosella ^c   D'Ambrosio, Lia ^c,d   Migliori, Giovanni Battista ^c  

^a UNIVERSITY OF SASSARI   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c IRCCS   (Italy)

^d Public Health Consulting Group SAGL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEDAQUILINE; DELAMANID; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; CLINICAL EFFECTIVENESS; DRUG SAFETY; DRUG TOLERABILITY; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HIGH INCOME COUNTRY; HUMAN; LETTER; MULTIDRUG RESISTANT TUBERCULOSIS; ONSET AGE; PEDIATRICS; PHASE 2 CLINICAL TRIAL (TOPIC); POPULATION DISTRIBUTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; HUMANS; TUBERCULOSIS;

EID: 84986184300     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01289-2016     Document Type: Letter

References (9)

1. Pontali E, Sotgiu G, D'Ambrosio L, et al. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence. Eur Respir J 2016; 47: 394-402.
2. Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis 2016; in press [DOI: 10.1016/S1473-3099(16)30132-3].
3. Tadolini M, Garcia-Prats AJ, D'Ambrosio L, et al. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges. Eur Respir J 2016; 48: 938-943.
4. World Health Organization. Global Tuberculosis Report 2015. (Document WHO/HTM/TB/2015.22). Geneva, World Health Organization, 2015.
5. Ettehad D, Schaaf HS, Seddon JA, et al. Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 449-456.
6. Migliori GB, Manissero D, Sotgiu G. Multidrug-resistant tuberculosis in children can be treated. Lancet Infect Dis 2012; 12: 425-426.
7. Nachman S, Ahmed A, Amanullah F, et al. Towards earlier inclusion of children in tuberculosis drug trials: a consensus statement. Lancet Infect Dis 2015; 15: 711-720.
8. Sotgiu G, Humbert M, Dinh-Xuan AT, et al. Clinical trials: registration and transparency. Eur Respir J 2016; 47: 1342-1344.
9. Sotgiu G, Mauch V, Migliori GB, et al. Evidence-based, agreed-upon health priorities to remedy the tuberculosis patient's economic disaster. Eur Respir J 2014; 43: 1563-1566.